| 355.89 Delayed Data As of 6:30pm ET |  +1.76 / +0.50%Today’s Change | 220.05 Today|||52-Week Range 358.89 | +53.26% Year-to-Date |
| Here's Why Fluidigm Stock Lost as Much as 54.2% Today Nov 06 / MotleyFool.com - Paid Partner Content | Bio-Rad Laboratories Inc (BIO) (BIO-B) Q3 2019 Earnings Call Transcript Nov 04 / MotleyFool.com - Paid Partner Content |
| Previous close | 354.13 |
| Today’s open | 355.58 |
| Day’s range | 354.68 - 357.60 |
| Volume | 136,891 |
| Average volume (3 months) | 213,515 |
| Market cap | $8.8B |
| Earnings growth (last year) | +197.26% |
| Earnings growth (this year) | +22.86% |
| Earnings growth (next 5 years) | +18.88% |
| Revenue growth (last year) | +5.98% |
| P/E ratio | 28.3 |
| Price/Sales | 3.07 |
| Price/Book | 2.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| QGENQiagen NV | +3.28 | +8.80% |
| PKIPerkinElmer Inc | +2.83 | +3.21% |
| BRKRBruker Corp | +0.31 | +0.63% |
| WATWaters Corp | +3.84 | +1.80% |
| Next reporting date | February 27, 2020 |
| EPS forecast (this quarter) | $2.43 |
| Annual revenue (last year) | $2.3B |
| Annual profit (last year) | $365.6M |
| Net profit margin | 15.97% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hercules, California |
